Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Serine Peptidase inhibitor Kunitz type 2 (SPINT2) ELISA Kit-Sandwich

Name: Bovine Serine Peptidase inhibitor Kunitz type 2 (SPINT2) ELISA Kit-Sandwich
SKU: EK10F293
Rating: 5 (1 reviews)

Cat. No.EK10F293

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Bovine SPINT2 ELISA Kit-Sandwich is designed for the quantitative determination of Bovine serine peptidase inhibitor, Kunitz type 2 (SPINT2) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Bovine SPINT2.

Target Species Bovine

Species Reactivity Bovine

Detection Range 32-2000 pg/mL

Sensitivity 6.25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Serine peptidase inhibitor Kunitz type 2 is encoded by the SPINT2 gene in cattle. It has been implicated as a suppressor in the neoplastic progression of keratinocytes.

Target/Biomarker Bovine SPINT2

Target Synonym serine peptidase inhibitor Kunitz type 2; kunitz-type protease inhibitor 2

Gene ID 507484

UniProt ID Q2KJ54

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Yamamoto, K. et al. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells. Oncotarget. 2018, 9: 11691-11706.